3D bioprinting is an advanced additive manufacturing technique that utilizes biomaterials, living cells, and active biomolecules to create structures that replicate the properties of natural tissues. Unlike traditional 3D printing, bioprinting integrates living cells with non-toxic hydrogels that mimic the extracellular matrix, promoting cell adhesion, proliferation, and differentiation post-printing. The process starts with 3D imaging to capture the precise dimensions of the tissue to be printed, followed by creating a digital model for layer-by-layer construction of a physical object. To maintain high cell viability and resolution, sterile conditions are essential. Biomaterials such as alginate, collagen, and gelatin are combined with living cells to form bioink, which is then deposited using extrusion, inkjet, or laser-based printing techniques. The 3D tissue constructs solidify through UV light, chemical stimulation, or heat, providing a stable environment for cell growth. 3D bioprinting has become an invaluable tool in drug testing, clinical trials, functional organ replacement, regenerative medicine, and the development of bio-printed applications in cosmetics and personal care. Ongoing research aims to refine materials and techniques to closely replicate the mechanical properties of various tissues, including skin, bone, cartilage, neural, cardiac, muscular, and dental tissues.